Early therapyMeSH concept

https://www.academie-medecine.fr/attention-au-contact-etroit-des-enfants-au-domicile-avec-des-animaux-de-compagnie-non-traditionnels-acnt-2/
2025
France
scientific and technical information
preventive treatment, nos
fibrosis, nos
secondary prevention
fibrosis
early therapy
early diagnosis
no diagnosis
kidney, nos

---
https://www.srlf.org/REACTU/traitement-antifongique-precoce-guide-b-glucanes-sepsis-fausse-bonne-idee
2023
France
critical appraisal or critical reading
glucans
early therapy
Antifungal agents
antifungal agents
sepsis
polyglucosan
Handbook
secondary prevention
polyglucosan

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/radiotherapie-adjuvante-pour-le-traitement-du-cancer-du-sein-de-stade-precoce-efficacite-et-innocuite-dune-irradiation-complete-du-sein-en-5-fractions-ultra-hypofractionnement.html
2022
Canada
practice guideline
radiation therapy, nos
Radiation Exposure
early
secondary prevention
Breast cancer
breast cancer
neoplasm, malignant
efficiency
radiotherapy, adjuvant
neoplasm staging
early therapy
adjuvant, nos
breast neoplasms

---
https://conseil-scientifique.public.lu/fr/publications/covid-19/traitement-precoce-de-la-covid-patients.html
2022
false
false
false
France
COVID-19
practice guideline
secondary prevention
early therapy
patients
has patient

---
https://dumas.ccsd.cnrs.fr/dumas-04056831
2022
France
dissertations, academic
efficiency
albumin/globulin ratio
early therapy
COVID-19
pharmacovigilance
secondary prevention
research report

---
https://www.has-sante.fr/jcms/p_3274374/fr/traitement-par-un-medicament-en-acces-precoce-ce-qu-il-faut-savoir
2021
France
patient education handout
early therapy
drug therapy
secondary prevention
drug, nos
knowledge
Handbook

---
https://pgtmsite.files.wordpress.com/2024/01/20_822_05_fongemie_non-neutro_ped-1.pdf
2021
false
false
false
Canada
algorithms
neutropenia
early therapy
infant, newborn
patients
has patient
systemic mycosis, nos
fungemia
pediatrics
Neutropenia
yeast, nos
Fungemia
yeasts
secondary prevention
pediatrician
Pediatricians
newborn, nos
neutropenia, nos

---
https://pgtmsite.files.wordpress.com/2024/01/20_822_05_fongemie_neutro_ped-1.pdf
2021
false
false
false
Canada
algorithms
neutropenia, nos
Neutropenia
Fungemia
early therapy
yeasts
systemic mycosis, nos
pediatrics
patients
secondary prevention
Pediatricians
newborn, nos
fungemia
neutropenia
yeast, nos
has patient
pediatrician
infant, newborn

---
https://www.armb.be/fileadmin/sites/armb/uploads/Document-site/pdf/Avis/2021/Avis_anticorps_monoclonaux_COVID_19_NL_FR.pdf
2021
Belgium
coronavirus infections
pneumonia, viral
public health guidelines
immunocompromised host
secondary prevention
Severe acute respiratory syndrome-related coronavirus
blood group antibody covas
antibodies, anti-idiotypic
spouses
has patient
antibodies
early therapy
antibodies
pandemics
COVID-19

---
https://www.cochrane.org/fr/CD012826/WOUNDS_la-chirurgie-au-jet-deau-haute-pression-hydrochirurgie-est-elle-meilleure-que-la-chirurgie
2020
false
false
false
France
United Kingdom
review of literature
french abstract
pressure
Surgery
operative procedure, nos
water
deep
burns
early therapy
uterine artery embolization
Burn
Water
burn injury, nos
Water
general surgery
water
Burns
secondary prevention
pressure, nos

---
http://www.theses.fr/2019LORR0039
2019
France
dissertations, academic
early
schizophrenia, nos
early therapy
Schizophrenia
Schizophrenia
Visual hallucination
Schizophrenia
schizophrenia
secondary prevention
hallucinations
Electronic Data Processing
visual hallucination
information processing
patient given information
vision, nos
hallucinations, visual
schizophrenia
consumer health information

---
http://www.cochrane.org/fr/CD012200/les-medicaments-modificateurs-de-la-maladie-pour-les-personnes-presentant-une-premiere-crise
2017
false
false
false
France
United Kingdom
French
french abstract
Persons with Disabilities
multiple sclerosis
recurrence
early therapy
treatment outcome
review of literature
cladribine
immunologic factors
Glatiramer Acetate
Interferon beta-1b
Interferon beta-1a
teriflunomide
placebos
comparative effectiveness research
immunologic factors
disability evaluation
secondary prevention
crotonates
toluidines

---